Jun Ohsumi

1.4k citations

31 papers · 1.2k indexed · h-index 18

Co-authors: Sachiko Sakakibara Kenji Miyadai Junko Yamaguchi Shu Takahashi Yo Takiguchi Noriaki Kume Manabu Minami Toru Kita
Topics: Peroxisome Proliferator-Activated Receptors (14 papers)Metabolism, Diabetes, and Cancer (14 papers)Adipose Tissue and Metabolism (4 papers)
Cited by: Immunology Oncology Biochemistry
Journals: Journal of Biological Chemistry The Journal of Immunology Analytical Chemistry
Partner nations: Japan Germany United States

In The Last Decade

Jun Ohsumi

31 papers receiving 1.2k citations

Peers

Countries citing papers authored by Jun Ohsumi

Since Specialization

Citations

This map shows the geographic impact of Jun Ohsumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Ohsumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Ohsumi more than expected).

Fields of papers citing papers by Jun Ohsumi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Ohsumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Ohsumi. The network helps show where Jun Ohsumi may publish in the future.

Co-authorship network of co-authors of Jun Ohsumi

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Ohsumi. A scholar is included among the top collaborators of Jun Ohsumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Ohsumi. Jun Ohsumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of DS-6930, a potent selective PPARγ modulator. Part II: Lead optimization 2018 ·Bioorganic & Medicinal Chemistry ·(unknown),(unknown),Kunihiko Fujii,(unknown),Kousei Shimada,Yoshiyuki Onishi,Yumi Matsui,(unknown),Masanori Kuroha,(unknown),Kazushi Araki,Jun Ohsumi,(unknown),Nobuaki Watanabe,Hideki Yamamoto,Kazunori Fujimoto,(unknown),Makoto Mori,Jun Tanaka	7
2	Discovery of DS-6930, a potent selective PPARγ modulator. Part I: Lead identification 2018 ·Bioorganic & Medicinal Chemistry ·(unknown),(unknown),Kunihiko Fujii,(unknown),Kousei Shimada,Yoshiyuki Onishi,Yumi Matsui,(unknown),Masanori Kuroha,(unknown),Kazushi Araki,Jun Ohsumi,(unknown),Nobuaki Watanabe,Hideki Yamamoto,Kazunori Fujimoto,(unknown),Makoto Mori,Jun Tanaka	11
3	Synthesis and biological evaluation of novel (−)-cercosporamide derivatives as potent selective PPARγ modulators 2012 ·European Journal of Medicinal Chemistry ·Akihiro Furukawa,Tsuyoshi Arita,Takehiro Fukuzaki,Makoto Mori,Takeshi Honda,Susumu Satoh,Yumi Matsui,Kenji Wakabayashi,(unknown),Kouichi Nakamura,Kazushi Araki,Masanori Kuroha,Jun Tanaka,(unknown),Osamu Suzuki,Jun Ohsumi	13
4	Substituents at the naphthalene C3 position of (−)-Cercosporamide derivatives significantly affect the maximal efficacy as PPARγ partial agonists 2011 ·Bioorganic & Medicinal Chemistry Letters ·Akihiro Furukawa,Tsuyoshi Arita,Takehiro Fukuzaki,Susumu Satoh,Makoto Mori,Takeshi Honda,Yumi Matsui,Kenji Wakabayashi,(unknown),Kazushi Araki,Jun Ohsumi	16
5	Discovery of novel SCD1 inhibitors: 5-Alkyl-4,5-dihydro-3H-spiro[1,5-benzoxazepine-2,4′-piperidine] analogs 2011 ·European Journal of Medicinal Chemistry ·Yoshikazu Uto,Yuko Ueno,Yohei Kiyotsuka,(unknown),Hitoshi Kurata,(unknown),Toshiyuki Takagi,(unknown),Jun Ohsumi	18
6	Discovery of a novel selective PPARγ modulator from (−)-Cercosporamide derivatives 2010 ·Bioorganic & Medicinal Chemistry Letters ·Akihiro Furukawa,Tsuyoshi Arita,Susumu Satoh,Kenji Wakabayashi,(unknown),Yumi Matsui,Kazushi Araki,Masanori Kuroha,Jun Ohsumi	16
7	Synthesis and evaluation of novel stearoyl-CoA desaturase 1 inhibitors: 1′-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-3,4-dihydrospiro[chromene-2,4′-piperidine] analogs 2010 ·European Journal of Medicinal Chemistry ·Yoshikazu Uto,Yuko Ueno,Yohei Kiyotsuka,(unknown),Hitoshi Kurata,(unknown),Makiko Yamada,Tsuneo Deguchi,Masahiro Konishi,Toshiyuki Takagi,(unknown),Jun Ohsumi	27
8	Novel benzoylpiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 6-[4-(2-methylbenzoyl)piperidin-1-yl]pyridazine-3-carboxylic acid (2-hydroxy-2-pyridin-3-ylethyl)amide and its plasma triglyceride-lowering effects in Zucker fatty rats 2009 ·Bioorganic & Medicinal Chemistry Letters ·Yoshikazu Uto,(unknown),Yohei Kiyotsuka,Yuko Ueno,(unknown),Hitoshi Kurata,Tsuneo Deguchi,Nobuaki Watanabe,Masahiro Konishi,Ryo Okuyama,Nobuya Kurikawa,Toshiyuki Takagi,(unknown),Jun Ohsumi	25
9	Novel spiropiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 1′-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-5-(trifluoromethyl)-3,4-dihydrospiro[chromene-2,4′-piperidine] 2009 ·Bioorganic & Medicinal Chemistry Letters ·Yoshikazu Uto,Yohei Kiyotsuka,Yuko Ueno,(unknown),Hitoshi Kurata,(unknown),Tsuneo Deguchi,Makiko Yamada,Nobuaki Watanabe,Masahiro Konishi,Nobuya Kurikawa,Toshiyuki Takagi,(unknown),Keita Kono,Jun Ohsumi	26
10	(−)-Cercosporamide derivatives as novel antihyperglycemic agents 2008 ·Bioorganic & Medicinal Chemistry Letters ·Akihiro Furukawa,Tsuyoshi Arita,Susumu Satoh,Kazushi Araki,Masanori Kuroha,Jun Ohsumi	8
11	CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats 2008 ·European Journal of Pharmacology ·(unknown),Akira Okuno,Masanori Izumi,Kanako Takahashi,(unknown),Jun Ohsumi,Toshihiko Fujiwara	18
12	High glucose potentiates palmitate‐induced NO‐mediated cytotoxicity through generation of superoxide in clonal β‐cell HIT‐T15 2003 ·FEBS Letters ·Ryo Okuyama,Toshihiko Fujiwara,Jun Ohsumi	18
13	Cutting Edge: SR-PSOX/CXC Chemokine Ligand 16 Mediates Bacterial Phagocytosis by APCs Through its Chemokine Domain 2003 ·The Journal of Immunology ·Takeshi Shimaoka,Takashi Nakayama,Noriaki Kume,Shu Takahashi,Junko Yamaguchi,Manabu Minami,Kazutaka Hayashida,Toru Kita,Jun Ohsumi,Osamu Yoshie,Shin Yonehara	133
14	Crystal Structure of the Antigen-Binding Fragment of Apoptosis-Inducing Mouse Anti-Human Fas Monoclonal Antibody HFE7A 2002 ·The Journal of Biochemistry ·(unknown),Tomoko Takayama,Hiroyuki Hanzawa,Kimihisa Ichikawa,Jun Ohsumi,Nobufusa Serizawa,Tadashi Hata,Hideyuki Haruyama	5
15	Increased Expression of the Sterol Regulatory Element-binding Protein-1 Gene in Insulin Receptor Substrate-2−/−Mouse Liver 2001 ·Journal of Biological Chemistry ·Kazuyuki Tobe,Ryo Suzuki,Masashi Aoyama,Toshimasa Yamauchi,Junji Kamon,Naoto Kubota,Yasuo Terauchi,Junji Matsui,Yasuo Akanuma,Satoshi Kimura,Jun Tanaka,Manabu Abe,Jun Ohsumi,Ryozo Nagai,Takashi Kadowaki	110
16	Cloning and Expression of a Novel Murine Anti-human Fas Antibody 2000 ·Bioscience Biotechnology and Biochemistry ·(unknown),Kimihisa Ichikawa,Junko Yamaguchi,Kenji Watanabe,Jun Ohsumi,Shin Yonehara,Nobufusa Serizawa	3
17	A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity 2000 ·International Immunology ·Kimihisa Ichikawa,(unknown),Masahiko Ohtsuki,Jun Ohsumi,Junko Yamaguchi,Shu Takahashi,(unknown),Mayumi Watanabe,Akio Shiraishi,Kusuki Nishioka,Shin Yonehara,Nobufusa Serizawa	46
18	Importance of the Carboxy-terminus of Human Interleukin-11 in Conserving Its Biological Activity 1996 ·Bioscience Biotechnology and Biochemistry ·Kenji Miyadai,Jun Ohsumi,(unknown),Ichiro Kawashima,Yasuhiro Ito	1
19	Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin‐11 1991 ·FEBS Letters ·Ichiro Kawashima,Jun Ohsumi,(unknown),(unknown),(unknown),Sachiko Sakakibara,Kenji Miyadai,Yo Takiguchi	128
20	Adipogenesis inhibitory factor A novel inhibitory regulator of adipose conversion in bone marrow 1991 ·FEBS Letters ·Jun Ohsumi,Kenji Miyadai,Ichiro Kawashima,(unknown),Sachiko Sakakibara,(unknown),Yo Takiguchi	28

About Jun Ohsumi

Jun Ohsumi is a scholar working on Molecular Biology, Immunology and Biochemistry, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (14 papers), Metabolism, Diabetes, and Cancer (14 papers) and Adipose Tissue and Metabolism (4 papers). The work is most often cited by research in Immunology (386 citations), Oncology (311 citations) and Biochemistry (78 citations). Jun Ohsumi has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Sachiko Sakakibara, Kenji Miyadai, Junko Yamaguchi, Shu Takahashi, Yo Takiguchi, Noriaki Kume, Manabu Minami, Toru Kita, Takashi Nakayama and Kazutaka Hayashida. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and Analytical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact